Bone marrow biopsies are the gold standard for diagnosing and monitoring the progression of multiple myeloma, but these procedures are far too invasive to perform at every patient visit. Scientists from the Dana-Farber Cancer ...
Apr 27, 2018
0
31
A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...
Apr 26, 2018
0
495
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...
Apr 19, 2018
0
28
Multiple myeloma is a rare incurable disease that is diagnosed in more than 30,000 people each year in the United States. Only half of patients with multiple myeloma are expected to survive five years after their diagnosis. ...
Mar 27, 2018
0
13
Researchers have identified two gene regions that contribute to multiple myeloma, an inherited cancer that occurs in bone marrow, through a new method that makes use of human disease pedigrees. Nicola Camp and Rosalie Waller ...
Feb 1, 2018
0
4
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy—which is limited to the skin and areas accessible with an endoscope—this technique can target and attack cancer cells that ...
Jan 26, 2018
0
230
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer—even after 30 years of stability. These are the findings of a study by Mayo Clinic researchers ...
Jan 17, 2018
0
3
The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new research from the Abramson Cancer Center of the University of Pennsylvania shows the therapy comes with the ...
Dec 28, 2017
0
6
Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following genetic changes in how the disease evolves over time will help to understand the disease and, ...
Dec 10, 2017
0
67
Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1. Using a database of multiple myeloma ...
Dec 5, 2017
0
2
